USA: S2N Health, Inc. has successfully secured seed funding to fuel the growth of the company’s RepSignal^TM medtech customer intelligence SaaS platform, and to develop a robust roadmap of AI-powered solutions for accelerating the market impact of healthcare technologies. The round was led by Excelerate Health Ventures, a premier digital health fund focused on healthcare software and technology-enabled services, with participation from other established healthcare and technology investors, including Boston Millennia Partners and Robin Hood Ventures.